Hormone replacement therapy and breast tissue density on mammography

Menopause

Volumn 9, Issue 2, 2002, Pages 82-83

  Slanetz, Priscilla J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; PROGESTERONE; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN; TIBOLONE;

BLOOD CLOTTING; BREAST; BREAST CANCER; BREAST CYST; CANCER RISK; CANCER SCREENING; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; DISEASE EXACERBATION; DOPPLER FLOWMETRY; DRUG EFFECT; EDITORIAL; ENDOMETRIUM CARCINOMA; FIBROADENOMA; FOLLOW UP; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; INSOMNIA; MAMMOGRAPHY; MASTALGIA; MOOD; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOPOROSIS; POSTMENOPAUSE; QUANTITATIVE ANALYSIS;

EID: 0036184952     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042192-200203000-00002     Document Type: Editorial

References (20)

1. A prospective study of postmenopausal estrogen therapy and coronary heart disease
2. The primary prevention of coronary heart disease in women
3. Hormone replacement therapy for prevention and treatment of osteoporosis
4. Hip fracture and the use of estrogens in postmenopausal women. The Framingham study
5. Mammographic changes associated with postmenopausal hormone replacement therapy: A longitudinal study
6. Mammographic and ultrasonographic study of changes in the breast related to HRT
7. Assessment of breast tissue changes on hormonal replacement therapy using MRI: A pilot study
8. Mammographic breast density during hormone replacement therapy: Differences according to treatment
9. Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy
10. Hormone replacement therapy rarely complicates or alters interpretation on screening mammography: A prospective analysis
11. Current perspectives on benefits and risks of hormone replacement therapy
12. The effect of hormone replacement therapy on the sensitivity of screening mammograms
13. Breast density as a predictor of mammographic detection: Comparison of interval and screen detected cancers
14. Mammographic patterns as a predictive biomarker of breast cancer risk: Effect of tamoxifen
15. Digitized mammography: A clinical trial of postmenopausal women randomly assigned to receive raloxifene, estrogen or placebo
16. Mammographic changes in women receiving tibolone therapy
17. Effects of tibolone on the breast
18. Mammographic changes associated with raloxifene and tibolone therapy in postmenopausal women: A prospective study
19. Mammographic density changes in postmenopausal women using tibolone therapy
20. Mammographic density changes during different postmenopausal hormone replacement therapies